Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CORAL: Zuranolone + ADT in MDD
NCT04476030Phase 3Completed
- Sponsor
- Biogen
- Start
- Nov 2020
- Primary completion
- Oct 2021
- Modality
- Allosteric Modulators
- Countries
- 1
01
Overview
A Phase 3 trial of zuranolone in major depressive disorder (MDD), sponsored by Biogen. Started Nov 2020; status: completed.
02
Drugs
zuranolone
03
Conditions
major depressive disorder (MDD)
Beyond the preview
Go deeper on NCT04476030.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04476030.